TickerTalks
Browse all tickers →
TickerTalks›$UNH
UNUNH

UnitedHealth Group Incorporated

$UNH·$386B·Medical - Healthcare Plans·Healthcare
$433.09+2.3%YTD+27.9%1Y+44.8%
Mentions · last 7 days
2026-07-10: 834 posts2026-07-11: 908 posts2026-07-12: 703 posts2026-07-13: 1,257 posts2026-07-14: 570 posts2026-07-15: 611 posts2026-07-16: 1,636 posts6,587+11%
Price updated 14m ago·X counts updated 19h ago
UNUNH
$UNHUnitedHealth Group Incorporated
$433.09+2.29%6.6k posts+11%
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Top X posts

Today's AI verdict on what's driving $UNH, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Comeback attemptAcceleratingAI verdict · as of 2026-07-17

The move is getting stronger, with heavier trading behind it.

The health-insurance giant just proved the reset quarter was real, and the tape is rewarding the recovery.

UnitedHealth is the largest US health insurer combined with Optum's care-delivery, pharmacy-benefit and analytics arms. Twelve months ago it was the pariah of the S&P; today the print says the medical-cost problem is starting to be under control and the Optum machine is still there.

What's driving the reversal:

  • Margin recovery is showing up in the numbers: Q1 operating margin came in at 8%, roughly double the prior three quarters when medical costs were blowing out, and EPS of $6.90 restored the trajectory to something like the historical run.
  • The revised outlook is what the market cares about: management delivered a rosy 2026 outlook with today's beat, RBC raised its target to $463, and consensus already has $18.40 in FY27 EPS — at 23x on that number the stock is not stretched given the earnings recovery.
  • Positioning was capitulated and is now reversing: Buffett sold out at the lows and a lot of active managers followed — a stock at 83% of the 52-week range on 2x volume is what a positioning short squeeze plus fresh institutional buying looks like.
  • Optum's AI monetization is a real add: the pymnts.com story ('UnitedHealth's AI bet paid off, now it's selling the playbook') points to Optum Insight licensing internal AI to peers — a small revenue line for now but the kind of structural mix shift that lifts the multiple.

The forward look: with earnings not until October 27 and a re-rated tape already at 15-month highs, the near-term risk is a Medicare Advantage bid-cycle or DOJ headline reopening the medical-cost fear, not the fundamentals. As long as the medical-cost ratio stays contained and the political rhetoric around PBMs stays chatter rather than legislation, the reset-trade has more room — but the easy repricing has been done.

Agrees with X sentimentThe X take that Buffett got shaken out at the lows and the tape has since vindicated the buyers matches the mechanics: this quarter is what the recovery looked like, and RBC's raised target line up with the beat and forward outlook.

What to watch: October 27 Q3 earnings and the annual Medicare Advantage bid update; any signal that the medical cost ratio is re-widening would end the accelerating leg fast.

On the calendar: 2026-10-27 — Q3 2026 earnings

X sentiment

What the X crowd is saying right now — descriptive, summarised from the day’s posts.

Bullish sentiment12 posts analyzed · as of 2026-07-15

UnitedHealth chatter is bullish healthcare rotation. UNH is back at $430 within touching distance of the 200 WMA. RBC Capital raised UNH PT to $463 from $400 with Outperform. Bulls describe adding aggressively when whales missed, Buffett sold out early, and flow said sell - now vindicated. Community groups UNH with LLY/TEM/OSCR/HUM as the healthcare-rotation basket. Traders take small overnight positions in UNH. Community broadly long-conviction.

Read the AI verdict + X sentiment for $UNH

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Largest U.S. health insurer and diversified health services company through Optum covering pharmacy, analytics, and primary care.

Industry overviewAI analysisGenerated by AI from underlying data

Where Medical - Healthcare Plans sits in its cycle right now — and what that implies for $UNH.

Medical - Healthcare Plans · Healthcare

No material change from last week — Oscar Health's AI-driven clinical platform is gaining member growth while the UNH Medicaid fraud litigation adds regulatory risk to legacy insurers.

What this means for $UNH

Partial — health insurer and diversified health services company through Optum covering pharmacy, analytics, and primary care; the AI-driven clinical platform growth vs. government payer headwind is a secondary rather than primary near-term earnings catalyst.

Top industry ETF

$IHFiShares U.S. Healthcare Providers ETF
+17.4%YTD
+26.7%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
30.2How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
8.1%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
4.2%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
5.4%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
0.8Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
12.4%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
18.8%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.7Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Jul 16, 2026$6.38$4.87+31.0%
Q1 2026Apr 21, 2026$7.23$6.46+11.9%
Q4 2025Jan 27, 2026$2.11$2.10+0.5%
Q3 2025Oct 28, 2025$2.92$2.80+4.3%
Next earningsTue, Oct 27·consensus EPS $3.73

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$111.7B+2.0%22.7%8.0%$6.90$8.1B
Q4 FY25$113.2B+12.3%16.3%0.3%$0.01$160.0M
Q3 FY25$113.2B+12.2%18.2%3.8%$2.59$5.1B
Q2 FY25$111.6B+12.9%17.9%4.6%$3.76$6.3B

Forward consensus

5-year forecast · up to 19 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$443.6B$438.9B – $450.5B$18.42$18.35 – $18.8018
FY27$457.3B$444.8B – $472.4B$20.99$19.68 – $21.9519
FY28$484.4B$484.1B – $484.7B$25.01$22.80 – $28.3416
FY29$514.2B$503.4B – $527.5B$30.55$29.71 – $31.5815
FY30$549.2B$537.7B – $563.5B$34.38$33.45 – $35.5515

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.2.0×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.83%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+5.4%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+24.2%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatHigh float · 905.4M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today1.5% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.635-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

SellApr 23Conway Patrick HughCEO800 sh$284K
+ 60 other (53 awards · 7 inkinds) in window

See when $UNH insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

8-KShareholder voteJun 58-K — Item 5.07: Shareholder vote
AI summary

UNH (UNH) disclosed the results of its annual meeting of shareholders in an 8-K filing under Item 5.07. Shareholders voted on an advisory say-on-pay resolution, ratification of the independent auditor, shareholder proposals. All management-sponsored proposals were approved by majority shareholder vote. Annual meeting results are a routine disclosure that confirms shareholder ratification of the board's composition and compensation practices.

8-KPress release / Reg FDMay 118-K — Item 7.01: Press release / Reg FD
AI summary

UNH filed an 8-K Item 7.01 (Reg FD) disclosure dated 2026-05-11. Relates to: Bank of America Securities Health Care Conference 2026 on Tuesday, May 12, 2026, beginning at 11:00. Reg FD disclosures make material information simultaneously available to all investors; content may include guidance updates, strategic plans, or preliminary results.

3New insider — initial holdingsMar 123
8-KPress release / Reg FDMar 98-K — Item 7.01: Press release / Reg FD
S-3ASRAuto-shelf registrationMar 2S-3ASR
8-KOfficer or director changeMar 28-K — Item 5.02: Officer or director change
8-KOfficer or director changeFeb 258-K — Item 5.02: Officer or director change
+ 11 other (3 earnings 8-Ks · 3 proxys · 2 13Gs · 1 11-K) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

UnitedHealth's AI Bet Paid Off. Now It Is Selling the Playbookpymnts.com·20h agoUnitedHealth Group Q2: The Real Test Begins Now (Downgrade)seekingalpha.com·1d agoUnitedHealth Stock Hits 2026 High on Strong Earnings, Rosy Outlookinvestopedia.com·1d agoUNH Rallies on Earnings, Question Marks in Health Insurers Remainyoutube.com·1d agoUnitedHealth Hits 15‑Month High: Congressional Trades That Suddenly Look Brilliantbenzinga.com·1d ago

More in Medical - Healthcare Plans

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$CVS$OSCR$ELV$CI$CNC$CLOV
Voices on X · top 13 · last 7 days

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport